These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7473127)

  • 1. Interindividual variation in expression of P-glycoprotein in normal human liver and secondary hepatic neoplasms.
    Schuetz EG; Furuya KN; Schuetz JD
    J Pharmacol Exp Ther; 1995 Nov; 275(2):1011-8. PubMed ID: 7473127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered expression of hepatic cytochromes P-450 in mice deficient in one or more mdr1 genes.
    Schuetz EG; Umbenhauer DR; Yasuda K; Brimer C; Nguyen L; Relling MV; Schuetz JD; Schinkel AH
    Mol Pharmacol; 2000 Jan; 57(1):188-97. PubMed ID: 10617694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of cytochrome P450 3A inhibitors with P-glycoprotein.
    Yasuda K; Lan LB; Sanglard D; Furuya K; Schuetz JD; Schuetz EG
    J Pharmacol Exp Ther; 2002 Oct; 303(1):323-32. PubMed ID: 12235267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue distribution of the human MDR3 P-glycoprotein.
    Smit JJ; Schinkel AH; Mol CA; Majoor D; Mooi WJ; Jongsma AP; Lincke CR; Borst P
    Lab Invest; 1994 Nov; 71(5):638-49. PubMed ID: 7734012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human intestinal P-glycoprotein activity estimated by the model substrate digoxin.
    Larsen UL; Hyldahl Olesen L; Guldborg Nyvold C; Eriksen J; Jakobsen P; Østergaard M; Autrup H; Andersen V
    Scand J Clin Lab Invest; 2007; 67(2):123-34. PubMed ID: 17365992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of human liver cytochromes P-450 in family 3A in primary and continuous culture of human hepatocytes.
    Schuetz EG; Schuetz JD; Strom SC; Thompson MT; Fisher RA; Molowa DT; Li D; Guzelian PS
    Hepatology; 1993 Nov; 18(5):1254-62. PubMed ID: 8225233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin.
    Mechetner E; Kyshtoobayeva A; Zonis S; Kim H; Stroup R; Garcia R; Parker RJ; Fruehauf JP
    Clin Cancer Res; 1998 Feb; 4(2):389-98. PubMed ID: 9516927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of P-glycoprotein genes in primary rat hepatocyte culture.
    Lee CH; Bradley G; Zhang JT; Ling V
    J Cell Physiol; 1993 Nov; 157(2):392-402. PubMed ID: 7901227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDR1 gene expression in primary and advanced breast cancer.
    Yang X; Uziely B; Groshen S; Lukas J; Israel V; Russell C; Dunnington G; Formenti S; Muggia F; Press MF
    Lab Invest; 1999 Mar; 79(3):271-80. PubMed ID: 10092063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Hepatogastroenterology; 2008; 55(86-87):1530-6. PubMed ID: 19102336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of multidrug resistance gene expression levels with malignant potentials and influence of chemotherapy in urothelial cancers.
    Kakehi Y; Wu WJ; Kim WJ; Arao S; Fukumoto M; Yoshida O
    Int J Urol; 1995 Nov; 2(5):309-15. PubMed ID: 8749949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of mdr1/P-glycoprotein and p110 in neuroblastoma.
    Ramani P; Dewchand H
    J Pathol; 1995 Jan; 175(1):13-22. PubMed ID: 7891222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations.
    Beck WT; Grogan TM; Willman CL; Cordon-Cardo C; Parham DM; Kuttesch JF; Andreeff M; Bates SE; Berard CW; Boyett JM; Brophy NA; Broxterman HJ; Chan HS; Dalton WS; Dietel M; Fojo AT; Gascoyne RD; Head D; Houghton PJ; Srivastava DK; Lehnert M; Leith CP; Paietta E; Pavelic ZP; Weinstein R
    Cancer Res; 1996 Jul; 56(13):3010-20. PubMed ID: 8674056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of P-glycoprotein in hepatocellular carcinoma. A determinant of chemotherapy response.
    Ng IO; Liu CL; Fan ST; Ng M
    Am J Clin Pathol; 2000 Mar; 113(3):355-63. PubMed ID: 10705815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P-glycoprotein expression in high grade central osteosarcoma and normal bone cells. An immunohistochemical study.
    Pösl M; Amling M; Grahl K; Hentz M; Ritzel H; Werner M; Winkler K; Delling G
    Gen Diagn Pathol; 1997 Jun; 142(5-6):317-25. PubMed ID: 9228255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular matrix regulation of multidrug resistance in primary monolayer cultures of adult rat hepatocytes.
    Schuetz JD; Schuetz EG
    Cell Growth Differ; 1993 Jan; 4(1):31-40. PubMed ID: 8424904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between the C3435T and G2677T(A) polymorphisms in the ABCB1 gene and P-glycoprotein expression in human liver.
    Owen A; Goldring C; Morgan P; Chadwick D; Park BK; Pirmohamed M
    Br J Clin Pharmacol; 2005 Mar; 59(3):365-70. PubMed ID: 15752383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of mitomycin C and carboplatin pretreatment on multidrug resistance-associated P-glycoprotein expression and on subsequent suppression of tumor growth by doxorubicin and paclitaxel in human metastatic breast cancer xenografted nude mice.
    Ihnat MA; Nervi AM; Anthony SP; Kaltreider RC; Warren AJ; Pesce CA; Davis SA; Lariviere JP; Hamilton JW
    Oncol Res; 1999; 11(7):303-10. PubMed ID: 10757444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal MDR1/ABCB1 level at surgery as a risk factor of acute cellular rejection in living-donor liver transplant patients.
    Masuda S; Goto M; Fukatsu S; Uesugi M; Ogura Y; Oike F; Kiuchi T; Takada Y; Tanaka K; Inui K
    Clin Pharmacol Ther; 2006 Jan; 79(1):90-102. PubMed ID: 16413244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.